News
Contact Us

One-Stop Clinical Development Solutions

Home > Our Solutions
Nonclinical
IND
Early Phase
Phase II-III
NDA/BLA
Post-Market

Early Clinical Development

Our independent central laboratory and GLP compliant biological analysis laboratory collaborate with quantitative pharmacology and clinical development teams to provide scientific clinical development strategies and plans, helping your project smoothly progress from preclinical to clinical.

  • Drug safety assessment: Preliminary understanding of the safety of drugs in the human body, including possible side effects, adverse reactions, etc
  • Optimal drug dosage: Through small-scale experiments, explore the effective dosage range of drugs in the human body, and provide reference for subsequent clinical trials
  • Precision dosing regimen: Study the absorption, distribution, metabolism, and excretion processes of drugs in the human body, providing a basis for developing dosing regimens


Pivotal Trial

SDM’s clinical team brings over 20 years of expertise in managing and executing large-scale clinical trials. We provide comprehensive support from trial design, patient recruitment, data management, quality control, risk management, statistical analysis and study reports.
  • Expertise across diverse therapeutic areas, including oncology, neurology, endocrinology, hepatology, pediatrics, and more.
  • Client-tailored clinical trial solutions to meet your product's specific needs.
  • A globally compliant quality management system and robust SOP framework ensure dynamic monitoring and efficient management of the entire clinical project lifecycle, delivering high-quality results on time and within budget. 


Post-Marketing Research

Our post-marketing clinical research team supports the development of refined medical strategies and real-world research to help extend product lifecycles, ensure greater patient benefit with high-quality research and evidence-based support.
  • Services include Phase IV trials, re-registration, traditional Chinese medicine registration, post-marketing safety studies, adverse event monitoring, real-world studies (RWS), investigator-initiated trials (IIT), and more.

Get in touch with SDM experts for your questions or comments and a member of our team will get back to you directly.

Let's Start a Conversation
First Name
Last Name
Email
Company
Title
Submit
Reject All
Accept All